血清IgA、IgG、IgM检测在前列腺炎疗效评估中的应用

doi:10.3969/j.issn.1673-8640.2018.12.008

摘要/Abstract

摘要：

目的探讨血清免疫球蛋白（Ig）A、IgG、IgM检测用于慢性前列腺炎患者疗效评估的可能性。方法检测115例慢性前列腺炎患者、115名体检健康者（正常对照组）的血清IgA、IgG、IgM水平,采用美国国家卫生研究院慢性前列腺炎症状指数（NIH-CPSI）量表（疼痛评分、排尿评分、生活质量评分、总分）在慢性前列腺炎患者治疗前进行评分,并于治疗6周后再次评分,以评价疗效。采用Pearson相关分析评估各项指标之间的相关性,采用多因素Logistic回归分析评估临床疗效与IgA、IgG、IgM的关系。结果慢性前列腺炎组血清IgA、IgG、IgM水平明显高于正常对照组（P=0.000）。高水平IgA、IgG、IgM的慢性前列腺炎患者NIH-CPSI量表评分均高于低水平IgA、IgG、IgM患者（P=0.000）。慢性前列腺炎患者血清IgA、IgG、IgM水平与NIH-CPSI量表评分均呈正相关（P<0.05）。不同疗效的慢性前列腺炎患者之间血清IgA、IgG、IgM水平差异均有统计学意义（P=0.000）。多因素Logistic回归分析显示,3个指标对慢性前列腺炎疗效的影响大小依次为IgG[比值比（OR）=5.003,95%可信区间（CI） 1.822~7.894]、IgA（OR=3.792,95%CI 3.302~7.580）、IgM（OR=2.599,95%CI 1.168~5.782）。结论血清IgA、IgG、IgM水平与慢性前列腺炎患者的临床症状及疗效有关。

关键词: 免疫球蛋白A, 免疫球蛋白G, 免疫球蛋白M, 慢性前列腺炎

Abstract:

Objective To investigate the roles of serum immunoglobulin（Ig）A,IgG and IgM determinations in the therapeutic effect evaluation of chronic prostatitis.Methods A total of 115 patients with chronic prostatitis and 115 healthy subjects（healthy control group） were enrolled. The National Institutes of Health-chronic prostatitis symptom index（NIH-CPSI） scale （pain score,urinary score,quality of life score and total score） was used before treatment and after treatment for 6 months,and the therapeutic effect evaluation was performed. The correlation was evaluated by Pearson correlation analysis. The correlations between therapeutic effect with IgA,IgG and IgM were analyzed by multivariant Logistic regression analysis.Results Serum IgA,IgG and IgM levels in chronic prostatitis group were higher than those in healthy control group （P=0.000）. In patients with chronic prostatitis with high IgA,IgG and IgM levels,NIH-CPSI scale was higher than those in patients with low IgA,IgG and IgM levels （P=0.000）. Serum IgA,IgG and IgM levels of chronic prostatitis patients were positively correlated with NIH-CPSI scale（P<0.05）. Serum IgA,IgG and IgM levels of chronic prostatitis patients with different therapeutic effects had statistical significance （P=0.000）. Multivariant Logistic regression analysis showed that the influence of serum IgA,IgG and IgM for the treatment of chronic prostatitis from high to low were IgG [odds ratio （OR）=5.003,95% confidence interval （CI）1.822-7.894],IgA（OR=3.792,95%CI 3.302-7.580） and IgM（OR=2.599,95%CI 1.168-5.782）.Conclusions Serum IgA,IgG and IgM have relations with the clinical symptoms and the therapeutic effect of chronic prostatitis.

Key words: Immunoglobulin A, Immunoglobulin G, Immunoglobulin M, Chronic prostatitis

中图分类号:

R446.1

王家芷, 王成. 血清IgA、IgG、IgM检测在前列腺炎疗效评估中的应用[J]. 检验医学, 2018, 33(12): 1094-1097.

WANG Jiazhi, WANG Cheng. Serum IgA,IgG and IgM determinations in the therapeutic effect evaluation of prostatitis[J]. Laboratory Medicine, 2018, 33(12): 1094-1097.

图/表 5

参考文献 13

1	CAI T,PISANO F,MAGRI V,et al.Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study[J]. J Sex Med,2014,11(12):3085-3092.
2	JIANG W,LU J Q,YANG L V, et al.Comparison study of distinguishing cancerous and normal prostate epithelial cells by confocal and polarization diffraction imaging[J]. J Biomed Opt,2016,21(7):71102.
3	娄敬. 广西防城港地区男性血清免疫球蛋白与前列腺炎样症状、EPS中白细胞数量的相关性的调查研究[D]. 南宁:广西医科大学,2014.
4	KRIEGER J N,NYBERG Jr,NICKEJ C.NIH consensus definition and classification of prostatitis[J]. JAMA,1999,282(3):236-237.
5	张敏建,宾彬,商学军,等. 慢性前列腺炎中西医结合诊疗专家共识[J]. 中国中西医结合杂志,2015,35(8):933-941.
6	毕焕洲. 尿炎消冲剂对细菌性前列腺炎大鼠血IL-2、IgG及TNF-α水平的影响[J]. 中国性科学,2008,17(7):12-14.
7	郭伟钊. 中医中药治疗慢性前列腺炎疗效和对IgA、IgG的影响[J]. 中国医学工程,2015,23(8):58-59.
8	张浩. 慢性非细菌性前列腺炎全身免疫机制探讨和临床研究[D]. 南宁:广西医科大学,2015.
9	霍山,谢群,方小武,等. 慢性前列腺炎患者血清抗精子抗体和精液参数变化[J]. 中国综合临床,2004,20(6):538-539.
10	周旋,吴旭泽,林钢,等. 前列消治疗慢性非细菌性前列腺炎44例[J]. 辽宁中医学院学报,2002,4(3):200-201.
11	GIBSON L,TAN A S,FRERES D,et al.Nonmedical information seeking amid conflicting health information: negative and positive effects on prostate cancer screening[J]. Health Commun,2016,31(4): 417-424.
12	邱晓剑,庄永泽,杨家辉,等. 慢性前列腺炎与IgA肾病关系初探[J]. 解放军医学杂志,2006,31(2):106-108.
13	SILBERSTEIN J L,TAYLOR M N,ANTONARAKIS E S.Novel insights into molecular indicators of response and resistance to modern androgen-axis therapies in prostate cancer[J]. Curr Urol Rep,2016,17(4):29.

组别	IgA	IgG	IgM
慢性前列腺炎组	3.88±0.42^*	18.70±4.32^*	2.78±0.17^*
正常对照组	1.95±0.27	8.42±2.56	0.88±0.30

组别	IgA	IgG	IgM
慢性前列腺炎组	3.88±0.42^*	18.70±4.32^*	2.78±0.17^*
正常对照组	1.95±0.27	8.42±2.56	0.88±0.30

项目	疼痛评分	排尿异常评分	生活质量评分	总分
IgA
高水平	9.57±2.52	6.07±2.05	6.41±1.63	26.87±4.99
低水平	4.23±1.39^*	4.87±1.85^*	5.07±1.47^*	12.58±4.63^*
IgG
高水平	10.58±1.78	5.87±1.41	6.89±2.28	26.97±4.45
低水平	5.72±2.46^*	4.82±1.24^*	4.89±1.52^*	9.78±3.41^*
IgM
高水平	11.71±3.47	6.12±1.24	6.47±2.45	27.40±3.15
低水平	5.14±3.07^*	5.08±1.68^*	4.66±2.75^*	10.75±2.78^*

项目	疼痛评分	排尿异常评分	生活质量评分	总分
IgA
高水平	9.57±2.52	6.07±2.05	6.41±1.63	26.87±4.99
低水平	4.23±1.39^*	4.87±1.85^*	5.07±1.47^*	12.58±4.63^*
IgG
高水平	10.58±1.78	5.87±1.41	6.89±2.28	26.97±4.45
低水平	5.72±2.46^*	4.82±1.24^*	4.89±1.52^*	9.78±3.41^*
IgM
高水平	11.71±3.47	6.12±1.24	6.47±2.45	27.40±3.15
低水平	5.14±3.07^*	5.08±1.68^*	4.66±2.75^*	10.75±2.78^*

指标	疼痛评分	排尿异常评分	生活质量评分	总分
IgA
r值	0.232	0.357	0.456	0.000
P值	0.031	0.034	0.015	0.611
IgG
r值	0.382	0.249	0.195	0.748
P值	0.041	0.024	0.021	0.000
IgM
r值	0.325	0.344	0.261	0.666
P值	0.018	0.038	0.020	0.000